Evidence map›Paper›PMID 28781961›Full record

ArticleFEBS open bio2017

Anthranilate phosphoribosyltransferase from the hyperthermophilic archaeon

Sumera Perveen, Naeem Rashid, Xiao-Feng Tang, Tadayuki Imanaka, Anastassios C Papageorgiou

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Structure, mechanism and inhibition of anthranilate phosphoribosyltransferase.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  5. A comprehensive review and comparison of L-tryptophan biosynthesis inFrontiers in bioengineering and biotechnology · 2023
    Review
  6. Crystal structures of anthranilate phosphoribosyltransferase from Saccharomyces cerevisiae.Acta crystallographica. Section F, Structural biology communications · 2021
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Sumera PerveenSchool of Biological Sciences University of the Punjab Lahore Pakistan.
Naeem RashidSchool of Biological Sciences University of the Punjab Lahore Pakistan.
Xiao-Feng TangDepartment of Microbiology College of Life Sciences Wuhan University Hubei Province China.
Tadayuki ImanakaThe Research Organization of Science and Technology Ritsumeikan University Kusatsu Shiga Japan.
Anastassios C PapageorgiouTurku Centre for Biotechnology University of Turku and Åbo Akademi University Finland.ORCID 0000-0002-7980-1120
Åbo Akademi University · FIRitsumeikan University · JPUniversity of the Punjab · PKWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthranilate phosphoribosyltransferase (TrpD) is involved in tryptophan biosynthesis, catalyzing the transfer of a phosphoribosyl group to anthranilate, leading to the generation of phosphoribosyl anthranilate. TrpD belongs to the phosphoribosyltransferase (PRT) superfamily and is the only member of the structural class IV. X-ray structures of TrpD from seven species have been solved to date. Here, functional and structural characterization of a recombinant TrpD from hyperthermophilic archaeon

Indexed as

crystal structurethermophilicitytryptophan biosynthesiszinc binding

Identifiers

PMID28781961
PMCPMC5537072
OpenAlexW2732287543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.